Newhall Charles W III
Supernus Pharmaceuticals, Inc. · Director
Newhall Charles W III is listed in filings as Director at Supernus Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Feb 25, 2026, including sale activity. Recent filings connect the profile to Supernus Pharmaceuticals, Inc. (SUPN). The current snapshot covers public activity from Aug 26, 2025 to Feb 25, 2026. Reported amounts are shown as $249.8K to $1.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $1.2M23.8k shares | SellOct 9, 2025 | $50.73 | $46.64 | |
| $62k1.2k shares | SellOct 9, 2025 | $51.55 | $46.64 |